Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation-Reference-Cited by-同舟云学术

Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation

Published:2015-11 Issue:8 Volume:29 Page:1203-1210
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Usui Ryota,Yabe Daisuke^ORCID,Kuwata Hitoshi,Murotani Kenta^ORCID,Kurose Takeshi,Seino Yutaka

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference45 articles.

1. Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes;Albareda;Diabetes Research and Clinical Practice,2005

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

3. U.K. prospective diabetes study 16. Overview of 6years' therapy of type II diabetes: A progressive disease. U.K. Prospective Diabetes Study Group;Diabetes,1999

4. Glycemic control over 5years in 4,900 people with type 2 diabetes: Real-world diabetes therapy in a clinical trial cohort;Best;Diabetes Care,2012

5. The triumvirate: β-Cell, muscle, liver. A collusion responsible for NIDDM;DeFronzo;Diabetes,1988

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PIONEER REAL Japan: Primary results from a multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice;Journal of Diabetes Investigation;2024-08-22

2. Efficacy and safety of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide in Japanese patients with type 2 diabetes mellitus;Diabetology International;2024-05-30

3. Retrospective Study of IDegLira, a New Fixed-Ratio Combination, in Japanese Patients With Type 2 Diabetes Mellitus: Analysis of Background Factors Affecting Effectiveness After 6 Months of Treatment;Journal of Clinical Medicine Research;2023-09

4. Retrospective Analysis of the Effectiveness of Oral Semaglutide in Type 2 Diabetes Mellitus and Its Effect on Cardiometabolic Parameters in Japanese Clinical Settings;Journal of Cardiovascular Development and Disease;2023-04-18

5. Advances in insulin therapy from discovery to β‐cell replacement;Journal of Diabetes Investigation;2022-09-08